SCHEMBL7779735

SCHEMBL7779735

NS(=O)(=O)c1ccc(-c2n[nH]c(C(F)(F)F)c2-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.57
CA1 P00915 7/20 0.54
CA2 P00918 7/20 0.54
CA9 Q16790 7/20 0.54
CA12 O43570 6/20 0.54
CA14 Q9ULX7 6/20 0.54
CA3 P07451 2/20 0.50
CA6 P23280 2/20 0.50
CA5A P35218 2/20 0.50
CA7 P43166 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.49
MAP2K4 P45985 4/20 0.46
MAPK1 P28482 2/20 0.46
MAPK6 Q16659 2/20 0.46
MAPKAPK3 Q16644 1/20 0.46
MAPKAPK5 Q8IW41 1/20 0.46
GYS1 P13807 6/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778114 0.88 LRRK2 (0.47) LRRK2PTGS2MAP2K4MAPK1MAPK6
SCHEMBL7773326 0.88 LRRK2 (0.68) LRRK2CA1CA2CA9CA12
SCHEMBL7780655 0.86 CA12 (0.57) LRRK2CA1CA2CA9CA12
SCHEMBL7773014 0.85 LRRK2 (0.61) LRRK2CA1CA2CA9CA12
SCHEMBL8975131 0.85 LRRK2 (0.52) LRRK2CA1CA2CA9CA12
SCHEMBL7779954 0.84 LRRK2 (0.60) LRRK2CA1CA2CA9CA12
SCHEMBL7779654 0.84 LRRK2 (0.60) LRRK2CA1CA2CA9CA12
SCHEMBL7777620 0.84 LRRK2 (0.60) LRRK2CA1CA2CA9CA12
SCHEMBL7773215 0.84 LRRK2 (0.77) LRRK2CA1CA2PTGS2MAP2K4
SCHEMBL7777551 0.82 CA1 (0.61) LRRK2CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed